RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All WHO updates
WHO
SAFETY ALERT
Webinar: Launch of WHO’s prequalification procedure for medical devices – 25 September 2026
Published: 10/28/2026Detected: 9/14/2026

Summary preview

Launches WHO’s prequalification procedure for medical devices, signaling a new, formal pathway for manufacturers seeking WHO-supported access to prioritized device markets.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
infectious_disease
cardiology
respiratory
oncology
neurology
immunology
pediatrics
ophthalmology
hematology
rare_diseases

Official Source Document
Source Verified

Access the original document directly from WHO.

View Official Document

More from WHO

  • Invitation to a Webinar on managing reportable changes11/16/2026
  • WHO Prequalifies Two STANDARD Q Malaria Rapid Diagnostic Tests11/16/2026
  • VCP Updates - October 202611/16/2026
  • In Vitro Diagnostics Assessment Sessions for 202711/16/2026
  • New WHO Emergency Use Listing for Ebola diagnostics11/16/2026

Get WHO alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
dermatology
psychiatry
gastroenterology
#WHO prequalification
#medical devices
#regulatory pathway
#quality management
#clinical performance
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.